Discoveries and Achievements
Read about the Childhood Solid Tumor Network, created to provide access to patient tumor samples and data to fuel research into pediatric solid tumors.
St. Jude researchers have found that cells of a deadly acute myeloid leukemia can be killed by blocking production of a molecular “battery.”
Agreement with Serum Institute of India to develop a vaccine for respiratory syncytial virus, a lower respiratory tract infection in infants and children.
The brain chemical adenosine may one day help adults learn language or music more easily.
Researchers have cracked the code for understanding how T cells recognize antigens that signal particular threats – and put it all in a useful algorithm
Health provider recommendation most important predictor of HPV vaccination of adolescent and young adult survivors of childhood cancer.
From Promise, Autumn 2017
Donate Now Promise Archive
Thank you for your feedback!
St. Jude scientists discover genes suspected to cause brain tumors in children. This discovery lays the foundation to expand targeted treatments.
Patients and families often praise
St. Jude clinical care and research. Find out why they have even more reasons to love the hospital.
At Delaware Bay, scientists gather crucial influenza data for research and vaccine development.
St. Jude creates a national referral clinic to advance cures for rare cancers of the endocrine system.
Stocks may rise and fall, but a long-term investment in the lives of children always pays dividends.
St. Jude continues its 25-year quest to raise the survival rate of childhood cancer for kids in China. Find out partnerships are making this possible.
St. Jude partner Brooks Brothers has raised more than $16 million. Read about how this doorman does his part to contribute.
Read a heartfelt thank you letter from Richard C. Shadyac, ALSAC president and CEO, to all
St. Jude supporters and volunteers.
A surprise proposal occurs in the hospital where one patient got a new chance at life.